Dingzhi Huang

机构：Tianjin Medical University Cancer Institute and Hospital

发表论文 25 篇 · 总被引 291 次 · h-index 7

代表论文

• Isolation and Identification of Cancer Stem-Like Cells in Esophageal Carcinoma Cell Lines (2008 · Stem Cells and Development · 被引 141)
• Ramosetron versus Ondansetron in the Prevention of Chemotherapy-Induced Gastrointestinal Side Effects: A Prospective Randomized Controlled Study (2007 · Chemotherapy · 被引 39)
• COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinib (2025 · ESMO Open · 被引 29)
• The first-in-class bispecific antibody IBI318 (LY3434172) targeting PD-1 and PD-L1 in patients with advanced tumors: a phase Ia/Ib study (2024 · Journal of Hematology & Oncology · 被引 19)
• Extrachromosomal DNA biogenesis is dependent on DNA looping and religation by YY1-Lig3-PARylation complex (2025 · Molecular Cell · 被引 10)
• [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor]. (2006 · PubMed · 被引 10)